ITMI20001053A0 - Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio - Google Patents

Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio

Info

Publication number
ITMI20001053A0
ITMI20001053A0 IT2000MI001053A ITMI20001053A ITMI20001053A0 IT MI20001053 A0 ITMI20001053 A0 IT MI20001053A0 IT 2000MI001053 A IT2000MI001053 A IT 2000MI001053A IT MI20001053 A ITMI20001053 A IT MI20001053A IT MI20001053 A0 ITMI20001053 A0 IT MI20001053A0
Authority
IT
Italy
Prior art keywords
procedures
preparation
optically active
therapeutic use
corresponding compositions
Prior art date
Application number
IT2000MI001053A
Other languages
English (en)
Inventor
Maurizio Delcanale
Gabriele Amari
Roberta Razzetti
Preti Pier Alessandro Monici
Ivano Rondelli
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL15275100A priority Critical patent/IL152751A0/xx
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ITMI20001053A0 publication Critical patent/ITMI20001053A0/it
Priority to IT2000MI001053A priority patent/IT1318516B1/it
Priority to BR0110989-8A priority patent/BR0110989A/pt
Priority to HU0302027A priority patent/HUP0302027A2/hu
Priority to US10/275,894 priority patent/US20040102652A1/en
Priority to JP2001582269A priority patent/JP2003532700A/ja
Priority to PCT/EP2001/005212 priority patent/WO2001085668A1/en
Priority to PL01357466A priority patent/PL357466A1/xx
Priority to AU2001274000A priority patent/AU2001274000A1/en
Priority to SK1605-2002A priority patent/SK16052002A3/sk
Priority to KR1020027014884A priority patent/KR20020094014A/ko
Priority to EP01940415A priority patent/EP1280759A1/en
Priority to CZ20023718A priority patent/CZ20023718A3/cs
Priority to ARP010102255A priority patent/AR028097A1/es
Priority to TNTNSN01072A priority patent/TNSN01072A1/fr
Publication of ITMI20001053A1 publication Critical patent/ITMI20001053A1/it
Priority to BG107259A priority patent/BG107259A/bg
Priority to NO20025393A priority patent/NO20025393L/no
Application granted granted Critical
Publication of IT1318516B1 publication Critical patent/IT1318516B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
IT2000MI001053A 2000-05-12 2000-05-12 Derivati 2-amminotetralinici otticamente attivi, procedimenti per laloro preparazione e impiego terapeutico delle corrispondenti IT1318516B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IL15275100A IL152751A0 (en) 2000-05-12 2000-05-08 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
IT2000MI001053A IT1318516B1 (it) 2000-05-12 2000-05-12 Derivati 2-amminotetralinici otticamente attivi, procedimenti per laloro preparazione e impiego terapeutico delle corrispondenti
AU2001274000A AU2001274000A1 (en) 2000-05-12 2001-05-08 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
EP01940415A EP1280759A1 (en) 2000-05-12 2001-05-08 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
US10/275,894 US20040102652A1 (en) 2000-05-12 2001-05-08 Optically active2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
JP2001582269A JP2003532700A (ja) 2000-05-12 2001-05-08 光学活性２−アミノテトラリン誘導体、その調製方法およびそれらを含む製薬学的組成物の治療的使用
PCT/EP2001/005212 WO2001085668A1 (en) 2000-05-12 2001-05-08 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
PL01357466A PL357466A1 (en) 2000-05-12 2001-05-08 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
BR0110989-8A BR0110989A (pt) 2000-05-12 2001-05-08 Derivados de 2-aminotetralina opticamente ativos, os processos para a preparação deles e uso terapêutico de composições farmacêuticas que os contêm
SK1605-2002A SK16052002A3 (sk) 2000-05-12 2001-05-08 Enantioméry 2-aminotetralínových derivátov, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
KR1020027014884A KR20020094014A (ko) 2000-05-12 2001-05-08 광학적 활성을 가진 2-아미노테트랄린 유도체, 그제조방법 및 이를 포함하는 약제성분의 치료방법
HU0302027A HUP0302027A2 (hu) 2000-05-12 2001-05-08 Optikailag aktív 2-aminotetralin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények terápiás alkalmazása
CZ20023718A CZ20023718A3 (cs) 2000-05-12 2001-05-08 Opticky aktivní 2-aminotetralinové deriváty, způsob jejich výroby a farmaceutický prostředek
ARP010102255A AR028097A1 (es) 2000-05-12 2001-05-11 Derivados npticamente activos de 2-aminotetralina, procesos para la preparacion de los mismos y uso terapcutico de composiciones farmaccuticas que los contienen
TNTNSN01072A TNSN01072A1 (fr) 2000-05-12 2001-05-11 Derives optiquement actifs du 2 - aminotetraline, les procedes de leur preparation et l'usage therapeutique des compositions pharmaceutiques contenant ces derives.
BG107259A BG107259A (bg) 2000-05-12 2002-11-08 Оптически активни 2-аминотетралинови производни, методи за получаването им и терапевтично приложение на фармацевтични състави, които ги съдържат
NO20025393A NO20025393L (no) 2000-05-12 2002-11-11 Optis 2-aminotetralinderivater, fremgangsmåte ved fremstilling derav og terapeutisk anvendelse av farmasöytisk anvendelse av farmasöytiskesammensetningerinneholdende dem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001053A IT1318516B1 (it) 2000-05-12 2000-05-12 Derivati 2-amminotetralinici otticamente attivi, procedimenti per laloro preparazione e impiego terapeutico delle corrispondenti

Publications (3)

Publication Number Publication Date
ITMI20001053A0 true ITMI20001053A0 (it) 2000-05-12
ITMI20001053A1 ITMI20001053A1 (it) 2001-11-12
IT1318516B1 IT1318516B1 (it) 2003-08-27

Family

ID=11445033

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001053A IT1318516B1 (it) 2000-05-12 2000-05-12 Derivati 2-amminotetralinici otticamente attivi, procedimenti per laloro preparazione e impiego terapeutico delle corrispondenti

Country Status (17)

Country Link
US (1) US20040102652A1 (it)
EP (1) EP1280759A1 (it)
JP (1) JP2003532700A (it)
KR (1) KR20020094014A (it)
AR (1) AR028097A1 (it)
AU (1) AU2001274000A1 (it)
BG (1) BG107259A (it)
BR (1) BR0110989A (it)
CZ (1) CZ20023718A3 (it)
HU (1) HUP0302027A2 (it)
IL (1) IL152751A0 (it)
IT (1) IT1318516B1 (it)
NO (1) NO20025393L (it)
PL (1) PL357466A1 (it)
SK (1) SK16052002A3 (it)
TN (1) TNSN01072A1 (it)
WO (1) WO2001085668A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
EP1384708A1 (en) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Process for the manufacture of form I of nolomirole hydrochloride

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
IT1269584B (it) * 1994-04-26 1997-04-08 Chiesi Farma Spa Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
IT1275935B1 (it) * 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.

Also Published As

Publication number Publication date
JP2003532700A (ja) 2003-11-05
NO20025393L (no) 2003-01-13
IL152751A0 (en) 2003-06-24
CZ20023718A3 (cs) 2003-02-12
WO2001085668A8 (en) 2002-02-21
ITMI20001053A1 (it) 2001-11-12
TNSN01072A1 (fr) 2005-11-10
US20040102652A1 (en) 2004-05-27
BG107259A (bg) 2003-07-31
WO2001085668A1 (en) 2001-11-15
KR20020094014A (ko) 2002-12-16
AU2001274000A1 (en) 2001-11-20
SK16052002A3 (sk) 2003-03-04
PL357466A1 (en) 2004-07-26
NO20025393D0 (no) 2002-11-11
AR028097A1 (es) 2003-04-23
BR0110989A (pt) 2003-12-30
EP1280759A1 (en) 2003-02-05
HUP0302027A2 (hu) 2003-10-28
IT1318516B1 (it) 2003-08-27

Similar Documents

Publication Publication Date Title
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
NO20030418L (no) Nytt farmasöytisk preparat
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
EE200100470A (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
DK1373249T3 (da) Imidazolidinderivater, deres fremstilling og deres anvendelse som anti-inflammatorisk middel
NO20034985L (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
ITPD20000193A0 (it) Nuovi derivati della cumarina e relativi sali, processo per la loro preparazione e loro impiego in campo farmaceutico.
ITMI991713A0 (it) Derivati 2-amminotetralinici per la terapia del glaucoma
ITTO20020674A0 (it) Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico
NO20030474D0 (no) Demens-legemiddel som inneholder 2-aryl-8- oksodihydropurinderivater som denaktive bestanddel
IT1312082B1 (it) Derivati morfinoidi, procedimento per la loro preparzione e loroimpiego terapeutico.
IT1317818B1 (it) Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,
ATA20092000A (de) Ophthalmologisches kurzkohärenz interferometer
ITBO20020022A0 (it) Composizioni farmaceutiche per la cura della pelle e il loro impiego
IT1307235B1 (it) Derivati del peg e loro impiego per la preparazione di coniugati diinteresse terapeutico.
IT1318623B1 (it) Procedimento per la preparazione di derivati dipeptidici.